tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

VALN Stock Latest News

Valneva Secures New $32.8 Million Contract for IXIARO® with U.S. Department of Defense
Company AnnouncementsValneva Secures New $32.8 Million Contract for IXIARO® with U.S. Department of Defense
22h ago
6K
VALN
Valneva Reports Positive Trial Results for Pediatric Chikungunya Vaccine
PremiumCompany Announcements
Valneva Reports Positive Trial Results for Pediatric Chikungunya Vaccine
8d ago
6K
VALN
Valneva reports Phase 2 results in children for its chikungunya vaccine
PremiumThe Fly
Valneva reports Phase 2 results in children for its chikungunya vaccine
9d ago
VALN
Valneva’s Chikungunya Vaccine Shows Promising Results in Adolescents
PremiumCompany Announcements
Valneva’s Chikungunya Vaccine Shows Promising Results in Adolescents
10d ago
6K
VALN
Valneva Engages Investors at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
Valneva Engages Investors at J.P. Morgan Healthcare Conference
24d ago
6K
VALN
Valneva and Serum Institute of India Collaborate to Tackle Chikungunya in Asia
PremiumCompany AnnouncementsValneva and Serum Institute of India Collaborate to Tackle Chikungunya in Asia
1M ago
6K
VALN
Valneva Highlights Chikungunya’s Global Economic Impact
Premium
Company Announcements
Valneva Highlights Chikungunya’s Global Economic Impact
2M ago
6K
VALN
Valneva’s Chikungunya Vaccine Shows Long-Lasting Efficacy
Premium
Company Announcements
Valneva’s Chikungunya Vaccine Shows Long-Lasting Efficacy
2M ago
6K
VALN
Valneva Seeks FDA Approval for Expanded Vaccine Use
PremiumCompany Announcements
Valneva Seeks FDA Approval for Expanded Vaccine Use
2M ago
6K
VALN
Valneva submits label extension application for chikungunya vaccine to FDA
PremiumThe Fly
Valneva submits label extension application for chikungunya vaccine to FDA
2M ago
VALN
Valneva Engages Investors with Promising Vaccine Developments
PremiumCompany Announcements
Valneva Engages Investors with Promising Vaccine Developments
3M ago
6K
VALN
Valneva SE Reports Profitable Nine-Month Performance
PremiumCompany Announcements
Valneva SE Reports Profitable Nine-Month Performance
3M ago
VALN
Valneva Reports Profitable Quarter Amid Vaccine Launches
PremiumCompany AnnouncementsValneva Reports Profitable Quarter Amid Vaccine Launches
3M ago
6K
VALN
Valneva’s Chikungunya Vaccine Gains Scientific Spotlight
Premium
Company Announcements
Valneva’s Chikungunya Vaccine Gains Scientific Spotlight
3M ago
6K
VALN
Valneva Gains FDA Fast Track for Shigella Vaccine
Premium
Company Announcements
Valneva Gains FDA Fast Track for Shigella Vaccine
4M ago
6K
VALN
Valneva reports FDA Fast Track Designation for shigella vaccine candidate
PremiumThe Fly
Valneva reports FDA Fast Track Designation for shigella vaccine candidate
4M ago
VALN
Valneva price target lowered to $20 from $23 at H.C. Wainwright
PremiumThe Fly
Valneva price target lowered to $20 from $23 at H.C. Wainwright
4M ago
VALN
Valneva Outlines Future Growth and Vaccine Pipeline
PremiumCompany Announcements
Valneva Outlines Future Growth and Vaccine Pipeline
4M ago
6K
VALN
Valneva Announces Investor Day to Showcase Vaccine Pipeline
PremiumCompany Announcements
Valneva Announces Investor Day to Showcase Vaccine Pipeline
4M ago
6K
VALN
Valneva price target lowered to $23 from $26 at H.C. Wainwright
PremiumThe FlyValneva price target lowered to $23 from $26 at H.C. Wainwright
4M ago
VALN
Valneva Seeks to Expand Chikungunya Vaccine Use
Premium
Company Announcements
Valneva Seeks to Expand Chikungunya Vaccine Use
4M ago
6K
VALN
Valneva Launches 60M Euro Share Placement for Vaccine Development
Premium
Company Announcements
Valneva Launches 60M Euro Share Placement for Vaccine Development
5M ago
6K
VALN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >